Joanne R. Soslow

Counseling clients in every phase of their growth cycles, Joanne advises on startup strategies, initial public offerings, change-of-control transactions, exit strategies, and corporate governance matters along the way. She often serves as the primary outside counselor to many of her clients, advising them on securities matters, M&A transactions, corporate governance matters, board of director and fiduciary duty issues, Sarbanes-Oxley compliance, and other legal needs. She frequently speaks at client and industry events on such topics as security industry trends and US Securities and Exchange Commission (SEC) initiatives.

Former chair of the firm's Global Steering Committee for Morgan Lewis Women, a founding member of the firm's Diversity Committee, and a former member of the firm's Advisory Board, Joanne mentors and supports women lawyers.In keeping with Morgan Lewis's commitment to pro bono work and community service, she is also a member of the Forum of Executive Women and the Trustee's Council of Penn Women.

Capital Markets Representations

• Represented AmeriGas Partners, L.P. in connection with its $1.35 billion public offering of senior notes
• Represented American Water Capital Corp. in connection with its $550 million offering of senior notes.
• Represented Antares Pharma, Inc. in connection with its $46 million public offering.
• Represented Cerecor Inc. in connection with its $26 million initial public offering.
• Represented Planet Payment, Inc. in connection with its tender offer to repurchase outstanding shares of common stock.
• Represented Tucows Inc. in connection with multiple tender offers to repurchase outstanding shares of common stock.

Corporate and Emerging Growth Representations

• Represented 1315 Capital in its $10.5 million Series A investment in Encore Dermatology.
• Represented Aprecia Pharmaceuticals Company in connection with its $35 million preferred stock financing with investments from Deerfield Management Company LP and JW Asset Management.
• Represented Aprecia Pharmaceuticals Company in securing a debt financing agreement of up to $30 million with Hercules Capital Inc.
• Represented Cervilenz in connection with its $6 million Series B financing.
• Represented Comcast Ventures in connection with its multiple investments including its investments in Bento Technologies Inc., KeyMe, Inc., Tely Labs, Madison Reed Inc., Windsor Circle, Axial, Fullscreen, Lead Intelligence, and SundaySky Ltd.
• Represented Lucina Health Inc. in its Series AA-1 financing from Arboretum Ventures, Chrysalis Ventures, Kresge VC, and Gray Fox Investments.
• Represented Nevakar in its $55 million fundraising

M&A Transactions

• Represented Acurian in connection with its sale to Pharmaceutical Product Development LLC.
• Represented InnoPharma in its sale to Pfizer.
• Represented Susquehanna Bancshares, Inc. in connection with its sale to BB&T Corporation for a cash and stock transaction.